CompletedNot Applicable

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.

44 participantsStarted 2010-03-10

Plain-language summary

Aloe vera is used for the treatment of inflammatory bowel disease (IBD), but no data are present in regard the gel formulation as topical therapy in active ulcerative colitis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age over 18 years, mild to moderate active ulcerative proctosigmoiditis, diagnosed for the first time and no therapy started before. The maximum extension of the disease was accepted of 40-60 cm from the anal verge or distal disease. Exclusion Criteria: * an extension of disease above the sigma, renal impairment, pregnancy, lactation or established low compliance

What they're measuring

endoscopic remission

Timeframe: 4 weeks

Trial details

NCT IDNCT04753775

SponsorOspedale Sandro Pertini, Roma

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-04-10

View on ClinicalTrials.gov More Aloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC) trials